Clinical Outcome of t-AML with Respect to Genetic Abnormalities and Treatment Intensity - Single Center Analysis over the Past Two Decades

Monika Adamska,Ewelina Kowal-Wisniewska,Marta Baranska,Anna Przybylowicz-Chalecka,Anna Lojko-Dankowska,Monika Joks,Zuzanna Kandula,Malgorzata Jarmuz-Szymczak,Lidia Gil

Blood（2021）

引用 0|浏览12

暂无评分

摘要

Background: Therapy-related acute myeloid leukemia (t-AML) represents emerging challenge of the modern oncology as a life-threatening complication of cytotoxic therapy. Disease characterises poor prognosis and presence of adverse cytogenetic and genetic abnormalities.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要